Vitrexyl Plus Iron Tablet
NDC Package 59088-165-54

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vitrexyl Plus Iron (ferrous fumarate, folic acid) tablets is vitrexyl + Iron is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age.Also for treatment of condition in which iron deficiency and vitamin C deficiency occur together, alongwith a deficient intake or increased need for B-Complex vitamins in chronic and acute illness, as well ascases of metabolic stress, and in convalescence. This formulation utilizes a tablet delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-165.

Identification & Billing

NDC Package Code
59088-165-54
Package Description
30 TABLET in 1 BOTTLE, PLASTIC
Product Code
59088-165
11-Digit Billing Format
59088016554

Clinical Specifications

Proprietary Name
Vitrexyl Plus Iron
Non-Proprietary Name
Ferrous Fumarate, Folic Acid
Substance Name
Chromium Nicotinate; Folic Acid; Vitamin A Acetate; Riboflavin; Niacinamide; Pyridoxine Hydrochloride; Cyanocobalamin; Calcium Carbonate; Ascorbic Acid; Thiamine Mononitrate; Zinc Oxide; Manganese Sulfate; Ferrous Fumarate; Magnesium Oxide; Molybdenum; .alpha.-tocopherol Acetate, Dl-; Cholecalciferol; Selenium
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Vitrexyl + Iron is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age.Also for treatment of condition in which iron deficiency and vitamin C deficiency occur together, alongwith a deficient intake or increased need for B-Complex vitamins in chronic and acute illness, as well ascases of metabolic stress, and in convalescence.

Regulatory & Marketing

Labeler Name
Puretek Corporation
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
08-24-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59088-165-54 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Vitrexyl Plus Iron, a human prescription drug labeled by Puretek Corporation. This tablet is formulated for oral use and contains chromium nicotinate; folic acid; vitamin a acetate; riboflavin; niacinamide; pyridoxine hydrochloride; cyanocobalamin; calcium carbonate; ascorbic acid; thiamine mononitrate; zinc oxide; manganese sulfate; ferrous fumarate; magnesium oxide; molybdenum; .alpha.-tocopherol acetate, dl-; cholecalciferol; selenium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on August 24, 2020. The current certification is valid through December 31, 2026.

How is this Puretek Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088016554. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59088-165-54
11-Digit CMS (5-4-2)
59088-0165-54

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.